Emergence of group a streptococcus strains with different mechanisms of macrolide resistance

被引:47
作者
Bingen, E
Leclercq, R
Fitoussi, F
Brahimi, N
Malbruny, B
Deforche, D
Cohen, R
机构
[1] Hop Robert Debre, Microbiol Serv, F-75019 Paris, France
[2] CHU Cote Nacre, Microbiol Serv, Caen, France
[3] Ctr Hosp Creteil, Microbiol Serv, F-94010 Creteil, France
关键词
D O I
10.1128/AAC.46.5.1199-1203.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mechanisms of resistance to macrolides in seven group A streptococcal (Streptococcuspyogenes) isolates that were the cause of pharyngitis in children who were unsuccessfully treated with azithromycin (10 mg/kg of body weight/day for 3 days) were evaluated. All posttreatment strains were found to be genetically related to the pretreatment isolates by random amplified polymorphism DNA analysis and pulsed-field gel electrophoresis. Two isolates had acquired either a mef(A) or an erm(B) gene, responsible for macrolide efflux and ribosomal modification, respectively. Three isolates displayed mutations in the gene encoding the L4 ribosomal protein that is part of the exit tunnel within the 50S subunit of the bacterial ribosome. In the two remaining posttreatment strains, the mechanisms of macrolide resistance could not be elucidated.
引用
收藏
页码:1199 / 1203
页数:5
相关论文
共 24 条
[1]  
ARAEIL B, 2001, J ANTIMICROB CHEMOTH, V48, P587
[2]   Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci [J].
Bert, F ;
Branger, C ;
LambertZechovsky, N .
CURRENT MICROBIOLOGY, 1997, 34 (04) :226-229
[3]   Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].
Bingen, E ;
Fitoussi, F ;
Doit, C ;
Cohen, R ;
Tanna, A ;
George, R ;
Loukil, C ;
Brahimi, N ;
Le Thomas, I ;
Deforche, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457
[4]   Short course therapy with ceftibuten versus azithromycin in pediatric streptococcal pharyngitis [J].
Boccazzi, A ;
Tonelli, P ;
De Angelis, MD ;
Bellussi, L ;
Passali, D ;
Careddu, P .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (10) :963-967
[5]   Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae [J].
Canu, A ;
Malbruny, B ;
Coquemont, M ;
Davies, TA ;
Appelbaum, PC ;
Leclercq, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :125-131
[6]   EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS [J].
CHOW, AW ;
HALL, CB ;
KLEIN, JO ;
KAMMER, RB ;
MEYER, RD ;
REMINGTON, JS .
CLINICAL INFECTIOUS DISEASES, 1992, 15 :S62-S88
[7]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[8]  
COHEN R, IN PRESS PEDIAT INFE
[9]   Complete genome sequence of an M1 strain of Streptococcus pyogenes [J].
Ferretti, JJ ;
McShan, WM ;
Ajdic, D ;
Savic, DJ ;
Savic, G ;
Lyon, K ;
Primeaux, C ;
Sezate, S ;
Suvorov, AN ;
Kenton, S ;
Lai, HS ;
Lin, SP ;
Qian, YD ;
Jia, HG ;
Najar, FZ ;
Ren, Q ;
Zhu, H ;
Song, L ;
White, J ;
Yuan, XL ;
Clifton, SW ;
Roe, BA ;
McLaughlin, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4658-4663
[10]   Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure of Streptococcus pyogenes pharyngitis [J].
Fitoussi, F ;
Cohen, R ;
Brami, G ;
Doit, C ;
Brahimi, N ;
delaRocque, F ;
Bingen, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (03) :233-237